Net Loss Per Share

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Net Loss Per Share

Net Loss Per Share

Basic and diluted net loss per share attributable to common shareholders of Biohaven was calculated as follows:

	Year Ended December 31,
	2024		2023		2022
Numerator:
Net loss	$	(846,422)	$	(408,168)	$	(570,279)
Denominator:
Weighted average common shares outstanding—basic and diluted	91,234,337		71,200,527		44,741,316
Net loss per share—basic and diluted	$	(9.28)	$	(5.73)	$	(12.75)

The Company's potential dilutive securities include share options which have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common shareholders of the Company is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common shareholders for the periods indicated because including them would have had an anti-dilutive effect:

	Year Ended December 31,
	2024	2023	2022
Options to purchase common shares	12,781,084	11,379,429	8,959,215
Warrants to purchase common shares	294,195	—	—
Restricted Share Units	277,221	—	—
	13,352,500	11,379,429	8,959,215